Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in Georgia
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Georgia
| Provider | Medicare | Services |
|---|---|---|
| Inman, John MD | $17.69 | 544 |
| Moseley, Thomas MD | $17.69 | 396 |
| Gee, Michael | $17.62 | 248 |
| Culbreth, Alexander MD | $17.69 | 205 |
| Hampton, Frank MD | $17.60 | 203 |
| Harris, Harvey | $17.51 | 193 |
| Cooper, William | $17.59 | 179 |
| Ahn, Kelly M.D. | $17.69 | 153 |
| Smith, Leon M.D. | $17.69 | 144 |
| Bishop, Craig D.O. | $17.69 | 128 |
| Daugherty, Dwayne M.D. | $17.69 | 126 |
Georgia Pricing in Context
In Georgia, CPT code G0328 (Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous) carries an average Medicare payment of $17.66 — 0% above the national benchmark of $17.63. 503 providers across the state submitted claims for this procedure in 2023, performing 10.2K total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Georgia is $54.07, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in Georgia lands near $39.73, with self-pay cash prices typically around $28.11. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost in Georgia?
The average Medicare payment for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in Georgia is $17.66, which is 0% above the national average of $17.63. Providers in GA typically bill $54.07 for this procedure.
What does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost with insurance in Georgia?
With commercial insurance in Georgia, Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs an estimated $39.73. Without insurance, the estimated cash price is $28.11. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in Georgia?
503 providers in Georgia billed Medicare for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in 2023, performing 10.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cheaper in Georgia than the national average?
No — Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs 0% above the national average in Georgia. The state average Medicare payment is $17.66 compared to $17.63 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.